LCA PHARMACEUTICAL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LCA PHARMACEUTICAL Trademark

Serial Number: 79203264 • Registration: 5420383

LCA PHARMACEUTICAL is a trademark filed by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA, on October 7, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,

9 Allée Prométhée

Entity Type: 33

Trademark Details

Filing Date

October 7, 2016

Registration Date

March 13, 2018

Published for Opposition

December 26, 2017

Cancellation Date

September 27, 2024

Goods & Services

Medical services; medical assistance; health counseling services; pharmacy advice, namely, medical advice related to pharmaceuticals; health care for human beings; advisory services and medical services in the field of rheumatology and dermatology; hygiene and beauty care; all the aforementioned services not in the field of ophthalmology

Surgical and medical apparatus and instruments, namely, sterile single use instrumentation for cataract surgery; Medical devices for intracorporal injection, namely, lenses in the nature of intraocular prostheses for surgical implantation packed in an injector; medical devices for intracorporeal injection; medical devices for intracorporeal injection consisting of a disposable sterile syringe; artificial implants, namely introcular implants; sterile intraocular implants of artificial material and medical devices for use in cataract surgery

Pharmaceutical products, namely, preparations for the treatment of osteoarthritis and other joint diseases; preparations for the treatment of pain and joint diseases, particularly osteoarthritis; injectable preparations for use in rheumatology, presented in the form of pre-filled disposable sterile syringes; preparations for dermatological use for filling in face wrinkles; pharmaceutical preparations for dermatological use; injectable preparations for dermatological use presented in the form of sterile pre-filled disposable syringes; Sterile, isotonic and preservative-free single doses for symptomatic treatments of eye irritations and for nose and eye care

Pharmaceutical research services; medical research services; scientific data analysis services; chemical analyses; chemical research; medical data analysis services; scientific research services for medical purposes, particularly design and development of implantable medical devices for use in ophthalmology, rheumatology and dermatology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Oct 2, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 2, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 27, 2025 INTR
CANCELLED SECTION 71
Sep 27, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 13, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 24, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jun 20, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Jun 20, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2017 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2017 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 14, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 14, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 14, 2017 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 21, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 21, 2017 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 9, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Mar 21, 2017 MAFR
NON-FINAL ACTION WRITTEN
Mar 20, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 16, 2017 REPR